Detalles de la búsqueda
1.
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
Support Care Cancer
; 28(10): 4825-4831, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982960
2.
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy.
Radiol Oncol
; 49(4): 409-15, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26834529
3.
Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib.
Respir Investig
; 62(3): 388-394, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38460356
4.
Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation.
Respir Med Case Rep
; 43: 101818, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36950026
5.
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.
Cancer Imaging
; 23(1): 23, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36859341
6.
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib.
Sci Rep
; 13(1): 20848, 2023 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012343
7.
Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis.
Can Respir J
; 2022: 3726395, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35663496
8.
A pregnant woman with severe dyspnoea.
Breathe (Sheff)
; 18(2): 220012, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36337132
9.
Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer.
Sci Rep
; 12(1): 11832, 2022 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35821395
10.
Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.
Cancers (Basel)
; 13(23)2021 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34885068
11.
A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia.
Radiol Case Rep
; 16(11): 3504-3508, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34422150
12.
Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations.
Thorac Cancer
; 11(8): 2351-2356, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32529804
13.
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment.
Thorac Cancer
; 11(8): 2188-2195, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495520
14.
Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC.
Anticancer Res
; 40(3): 1571-1578, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32132059
15.
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Thorac Cancer
; 11(10): 2867-2876, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32844570
16.
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
Cancer Chemother Pharmacol
; 85(4): 761-771, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32193618
17.
Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer.
Oncol Lett
; 17(3): 3569-3575, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30867799
18.
Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.
Lung Cancer
; 134: 180-186, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319979
19.
Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1.
Anticancer Res
; 39(3): 1455-1461, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30842182
20.
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer.
Anticancer Res
; 39(5): 2483-2491, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092443